CEBTF yields 18181.82% · PFE yields 6.13%● Live data
📍 CEBTF pulled ahead of the other in Year 1
Combined, CEBTF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CEBTF + PFE for your $10,000?
Citychamp Watch & Jewellery Group Limited, an investment holding company, manufactures, sells, and distributes watches and timepieces in Hong Kong, the People's Republic of China, Switzerland, the United Kingdom, Liechtenstein, and internationally. The company operates through Manufacturing and Distribution of Watches and Timepieces, Property Investments, and Banking and Financial Businesses segments. It offers watches and timepieces under the Rossini, Corum, Eterna, Dreyfuss & Co, J&T Windmills, Ernest Borel, and Rotary brands. The company is also involved in the property investment activities; distribution of glasses; and issuance of bonds. In addition, it operates a bank in Liechtenstein that offer financial services, including accepting client deposits and granting loans; and portfolio management, investment advice, transaction banking, and investment fund services for entrepreneurial families and individuals. Further, the company provides investment counselling services; acts as technical administrator of fund units; dealing and advising in securities; and watch maintenance and repairment, and technical advisory services, as well as acts as an alternative investment fund manager. The company was formerly known as China Haidian Holdings Limited and changed its name to Citychamp Watch & Jewellery Group Limited in May 2014. Citychamp Watch & Jewellery Group Limited is based in Kowloon, Hong Kong.
Full CEBTF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.